These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Regulation of p57(KIP2) during muscle differentiation: role of Egr1, Sp1 and DNA hypomethylation. Figliola R; Busanello A; Vaccarello G; Maione R J Mol Biol; 2008 Jul; 380(2):265-77. PubMed ID: 18513743 [TBL] [Abstract][Full Text] [Related]
23. Histone deacetylase inhibitors upregulate p57Kip2 level by enhancing its expression through Sp1 transcription factor. Cucciolla V; Borriello A; Criscuolo M; Sinisi AA; Bencivenga D; Tramontano A; Scudieri AC; Oliva A; Zappia V; Della Ragione F Carcinogenesis; 2008 Mar; 29(3):560-7. PubMed ID: 18204075 [TBL] [Abstract][Full Text] [Related]
24. Cyclic changes in the expression of p57(kip2) in human endometrium and its regulation by steroid hormones in endometrial stromal cells in vitro. Kim ST; Lee SK; Gye MC Reprod Sci; 2012 Jan; 19(1):92-101. PubMed ID: 22064387 [TBL] [Abstract][Full Text] [Related]
25. The cyclin kinase inhibitor p57kip2 regulates TGF-beta-induced compensatory tubular hypertrophy: effect of the immunomodulator AS101. Sinuani I; Weissgarten J; Beberashvili I; Rapoport MJ; Sandbank J; Feldman L; Albeck M; Averbukh Z; Sredni B Nephrol Dial Transplant; 2009 Aug; 24(8):2328-38. PubMed ID: 19321762 [TBL] [Abstract][Full Text] [Related]
26. The E2A splice variant E47 regulates the differentiation of projection neurons via p57(KIP2) during cortical development. Pfurr S; Chu YH; Bohrer C; Greulich F; Beattie R; Mammadzada K; Hils M; Arnold SJ; Taylor V; Schachtrup K; Uhlenhaut NH; Schachtrup C Development; 2017 Nov; 144(21):3917-3931. PubMed ID: 28939666 [TBL] [Abstract][Full Text] [Related]
28. Epigenetic down-regulation of CDKN1C/p57KIP2 in pancreatic ductal neoplasms identified by gene expression profiling. Sato N; Matsubayashi H; Abe T; Fukushima N; Goggins M Clin Cancer Res; 2005 Jul; 11(13):4681-8. PubMed ID: 16000561 [TBL] [Abstract][Full Text] [Related]
29. P21-activated kinase 4 regulates the cyclin-dependent kinase inhibitor p57(kip2) in human breast cancer. Li Y; Wang D; Zhang H; Wang C; Dai W; Cheng Z; Wang G; Li F Anat Rec (Hoboken); 2013 Oct; 296(10):1561-7. PubMed ID: 23873832 [TBL] [Abstract][Full Text] [Related]
30. CDKN1C/P57 is regulated by the Notch target gene Hes1 and induces senescence in human hepatocellular carcinoma. Giovannini C; Gramantieri L; Minguzzi M; Fornari F; Chieco P; Grazi GL; Bolondi L Am J Pathol; 2012 Aug; 181(2):413-22. PubMed ID: 22705236 [TBL] [Abstract][Full Text] [Related]
31. Expression of p21(Wafl/Cip1), p57(Kip2) and HER2/neu in patients with gallbladder cancer. Puhalla H; Wrba F; Kandioler D; Lehnert M; Huynh A; Gruenberger T; Tamandl D; Filipits M Anticancer Res; 2007; 27(3B):1679-84. PubMed ID: 17595796 [TBL] [Abstract][Full Text] [Related]
32. Downregulation of p57kip² promotes cell invasion via LIMK/cofilin pathway in human nasopharyngeal carcinoma cells. Chow SE; Wang JS; Lin MR; Lee CL J Cell Biochem; 2011 Nov; 112(11):3459-68. PubMed ID: 21769918 [TBL] [Abstract][Full Text] [Related]
33. High Dosage Lithium Treatment Induces DNA Damage and p57 Stampone E; Bencivenga D; Barone C; Aulitto A; Verace F; Della Ragione F; Borriello A Int J Mol Sci; 2020 Feb; 21(3):. PubMed ID: 32050593 [TBL] [Abstract][Full Text] [Related]
34. Expression of p57(KIP2) in hepatocellular carcinoma: relationship between tumor differentiation and patient survival. Nakai S; Masaki T; Shiratori Y; Ohgi T; Morishita A; Kurokohchi K; Watanabe S; Kuriyama S Int J Oncol; 2002 Apr; 20(4):769-75. PubMed ID: 11894123 [TBL] [Abstract][Full Text] [Related]
35. Age-dependent changes of p57(Kip2) and p21(Cip1/Waf1) expression in skeletal muscle and lung of mice. Park CW; Chung JH Biochim Biophys Acta; 2001 Aug; 1520(2):163-8. PubMed ID: 11513958 [TBL] [Abstract][Full Text] [Related]
36. Downregulation of cyclin-dependent kinase inhibitor; p57(kip2), is involved in the cell cycle progression of vascular smooth muscle cells. Nakano N; Urasawa K; Takagi Y; Saito T; Kaneta S; Ishikawa S; Higashi H; Tsutsui H; Hatakeyama M; Kitabatake A Biochem Biophys Res Commun; 2005 Dec; 338(3):1661-7. PubMed ID: 16259944 [TBL] [Abstract][Full Text] [Related]
37. BMP2 and BMP6 control p57(Kip2) expression and cell growth arrest/terminal differentiation in normal primary human epidermal keratinocytes. Gosselet FP; Magnaldo T; Culerrier RM; Sarasin A; Ehrhart JC Cell Signal; 2007 Apr; 19(4):731-9. PubMed ID: 17112701 [TBL] [Abstract][Full Text] [Related]
38. Different expression patterns of p27 and p57 proteins in benign and malignant melanocytic neoplasms and in cultured human melanocytes. Curry JL; Richards HW; Huttenbach YT; Medrano EE; Reed JA J Cutan Pathol; 2009 Feb; 36(2):197-205. PubMed ID: 18647205 [TBL] [Abstract][Full Text] [Related]
39. Comprehensive genotype-phenotype correlations between NLRP7 mutations and the balance between embryonic tissue differentiation and trophoblastic proliferation. Nguyen NM; Zhang L; Reddy R; Déry C; Arseneau J; Cheung A; Surti U; Hoffner L; Seoud M; Zaatari G; Bagga R; Srinivasan R; Coullin P; Ao A; Slim R J Med Genet; 2014 Sep; 51(9):623-34. PubMed ID: 25097207 [TBL] [Abstract][Full Text] [Related]
40. Lhx6 and Lhx8 promote palate development through negative regulation of a cell cycle inhibitor gene, p57Kip2. Cesario JM; Landin Malt A; Deacon LJ; Sandberg M; Vogt D; Tang Z; Zhao Y; Brown S; Rubenstein JL; Jeong J Hum Mol Genet; 2015 Sep; 24(17):5024-39. PubMed ID: 26071365 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]